Stories
STORIES
New to Care Across? Sign up to read all comments and join the conversation
News
>
Latest research available at a glance
Everolimus gets FDA approval for another indication
Everolimus got approved by the FDA for the treatment of inoperable, locally advanced or metastatic neuroendocrine tumors of gastrointestinal or lung origin.
CareAcross
Proton radiotherapy gives hope to childhood brain cancer patients
Treatment with proton radiotherapy in childhood brain cancer resulted in fewer side effects and similar survival rates as conventional radiotherapy.
CareAcross